AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 15, 2018 FORM 10-Q QUARTERLY REPORT
8-K May 11, 2018 CURRENT REPORT ON FORM 8-K
8-K Apr 18, 2018 FORM 8K CURRENT REPORT
424B5 Apr 18, 2018 424B5 PROSPECTUS SUPPLEMENT
4 Apr 6, 2018 PRIMARY DOCUMENT
8-K Apr 5, 2018 FORM 8K CURRENT REPORT
10-K Mar 15, 2018 FORM 10-K ANNUAL REPORT
10-Q Nov 20, 2017 FORM 10-Q QUARTERLY REPORT
NT 10-Q Nov 15, 2017 FORM NT 10-Q NOTICE OF LATE QUARTERLY FILING
EFFECT Sep 14, 2017
UPLOAD Sep 14, 2017
10-Q/A Sep 14, 2017 FORM 10QA AMENDED QUARTERLY REPORT
10-Q/A Sep 14, 2017 FORM 10QA AMENDED QUARTERLY REPORT
10-K/A Sep 14, 2017 FORM 10-KA AMENDED ANNUAL REPORT
UPLOAD Sep 14, 2017
CORRESP Sep 11, 2017
UPLOAD Sep 6, 2017
S-3 Aug 24, 2017 FORM S-3 REGISTRATION STATEMENT
10-Q Aug 21, 2017 FORM 10Q QUARTERLY REPORT
NT 10-Q Aug 14, 2017 FORM NT 10Q NOTICE OF LATE QUARTERLY FILING
8-K/A Jun 26, 2017 FORM 8K/A AMENDED CURRENT REPORT
3 Jun 23, 2017 PRIMARY DOCUMENT
3 Jun 23, 2017 PRIMARY DOCUMENT
3 Jun 23, 2017 PRIMARY DOCUMENT
3 Jun 23, 2017 PRIMARY DOCUMENT
← Newer Page 7 of 13 · 306 filings Older →